MYO
Medical Devices · Healthcare
CEO, Board Member
2026-06-25–present
Board Member
Myomo, Inc. (MYO)Equibles does not estimate personal net worth.
Get an email with a short summary when Myomo, Inc. publishes a filing, an earnings call transcript or a press release.
Get MYO alertsPaul R. Gudonis is recorded as Board Member at Myomo, Inc. (MYO) since June 25, 2026 and CEO at Myomo, Inc. (MYO). The newest filing on record that lists Paul R. Gudonis as CEO at Myomo, Inc. (MYO) is dated May 14, 2026. Myomo, Inc. reported in an 8-K filed June 26, 2026 that Paul R. Gudonis was appointed Class III director, effective June 25, 2026. The proxy statement of Myomo, Inc. reports total compensation of $1,201,183 for Paul R. Gudonis in fiscal 2025, including a base salary of $375,000. Disclosed compensation is on record for 5 fiscal years. Paul R. Gudonis has spoken on 15 earnings calls and 3 other investor events across 1 company, most recently for Myomo, Inc. on November 9, 2026. Myomo, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Myomo, Inc. includes David A. Henry (CFO), Heather C. Getz (Board Member), Joseph M. Manko (Board Member) and 5 others.
“The Company's stockholders approved the election of Paul R. Gudonis and Thomas F. Kirk as Class III directors to serve for a three-year term expiring at the Company's annual meeting of stockholders in 2029 and until their successors have been elected and qualified.”
“IOMO's purpose is to help people living with chronic arm and hand paralysis to regain function and independence with our powered arm braces. In the third quarter, we made progress in reaching more of these patients we serve while improving the economics of our business.”
“And you probably know someone with a paralyzed arm. because it's a 1% prevalence. You know, someone who's had a stroke, a spinal cord injury, brachial plexus injury from a motorcycle accident, a veteran might have been injured.”
“Our mission here at MIOMO remains straightforward to restore function and independence to people living with chronic arm and hand paralysis.”
“It's a pleasure to introduce MIOMO to you and also for existing investors to provide an update on our business progress here. So let me start by first reviewing our safe harbor statement about any forward-looking statements over here.”
“Well, good afternoon, and thank you all for joining us today.”
2026-06-25–present
Start not stated–present
Last confirmed May 14, 2026
MYO
Medical Devices · Healthcare
CEO, Board Member
2026-06-25–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Myomo, Inc. (MYO) | Chief Executive Officer | $375,000 | $1,201,183 |
| 2024 | Myomo, Inc. (MYO) | Chief Executive Officer | $348,077 | $1,240,467 |
| 2023 | Myomo, Inc. (MYO) | Chief Executive Officer | $300,000 | $663,900 |
| 2022 | Myomo, Inc. (MYO) | Chief Executive Officer | $300,000 | $526,043 |
| 2021 | Myomo, Inc. (MYO) | Chief Executive Officer | $268,154 | $957,572 |